,

.(15)
40 (40-70 .)
. (>5.2; HDL<1.26; TG>2.0 mmol/l)
, 90 3 x 250
.(15)

,
(13)

LDL


7
4.8
.(13)
6.8
4.6

6.45 0.23
6.6
4.25 0.20
,
4.4
6.4
/
4.2
.(18)
6.2
5.91 0.23
4
LDL,
6
3.71 0.21
(20)
3.8
HDL .
5.8

3.6
5.6
.(1)
3.4
5.4

(2)
3.2
5.2
.
5

Tribestan

Tribestan

Tribestan

4 :
(20) ., . , . , . , . . ribestan R
.
, ,2006,1,8-13.

Tribestan

2 3

- 90

1-2 3

- 90

3 1-2

1- 12-
( ).

(1) 26.11.2007 .
(2) , . TRIBESTAN - . 2007 (9): 1-2
(3) World Health Organisation. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge,UK: Cambridge University Press; 2003.
(4) Jungwirth, A et al. European Association of Urology Guidelines on Male Infertility:The 2012 Update. Eur Urol 2012 (62): 324-332
(5) Richard M. Sharpe. Environmental/lifestyle eects on spermatogenesis. Phil Trans R Soc B 2010; 365:1697-1712
(6) Tremellen, K. Oxidative stress and male infertilitya clinical perspective. Hum Reprod Update 2008 (14): 243-258
(7) Kulkarni, S. A et al. Levels of plasma testosterone, antioxidants and oxidative stress in alcoholic patients attending de-addiction centre. Biol and Med, 2009, 1(4): 11-20.
(8) Henkel, R. Leukocytes and oxidative stress: dilemma for sperm function and male fertility.Asian J Androl 2011(13):43-52
(9) Saad, F. The Role of Testosterone in Type 2 Diabetes and Methabolic Syndrome in Men. Arq Bras Endocrinol Metab. 2009; 901-907
(10) Grossmann, M. Et al. Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes. J Clin Endocrinol Metab. 2008, 93(5):1834-1840
(11) STEVEN M. et al. Insulin Resistance, Body Fat Distribution,and Sex Hormones in Men. Diabetes, 1994 (9): 212-219
(12) Navar, P. Optimizing Testosterone Levels in Aging Men. Life Exten 2008 (Jul):37-43
(13) Zheleva-Dimitrova, D. et al. Antioxidant activity of Tr ibulus terrestris a natural product in infertility therapy. Int J Phar mans Pharm Sci. 2012 (4):508-511
(14) Adimoelja A., P.G. Adaikan. Protodioscin from herbal plant Tribulus terrestris L improves the male sexual functions probably via DHEA Int. J. Impot Res, 9, 1997, Suppl. 1.
(15) Viktorof I., Bozadjieva E., Protich M., et al. Pharmacological, pharmacokinetic, toxicological and clinical studies on protodioscin. IIMS Therapeutic Focus Vol 2 (1994).
(16) Arsyad K.M. (1996) Result of Protodioscin (Tribulus terrestris) treatment in males diagnosed with infertility and impotence. [Accessed 2013 January 28] Available from http://www.libilov.
com/en/clinical_studies/review_Arsyad_1996.htm
(17) Gauthaman K., P.G. Adaikan. Eect of Tribulus terrestis on nicotinamide adenine dinucleotide phosphate-diaphorase activity and androgen receptors in rat brain. J Ethnopharmacol,
96,2005,127-132.
(18) Negro-Vilar,A. Stress and Other Environmental Factors Aecting Fertility in Men and Women:Overview. Environ Health Perspect. 1993 Jul;101 Suppl 2:59-64.
(19) Nikolova, V., R. Stanislavov Tribulus terrestris and human reproduction. Clinical laboratory data. European meeting of immunology and reproduction, Rome, October 28-29, 1999.
(20) ., . , . , . , . . ribestan R .
, ,2006,1,8-11.
(21) Aitken R. J.,Roman S. Antioxidant systems and oxidative stress in the testes. Oxid Med Cell Longev. 2008 Oct-Dec; 1(1): 1524. PMC2715191
(22) Shivakumar H. A current status of adaptogens: natural remedy to stress. Asian Pacic Journal of Tropical Disease (2012)S480-S490
. . 16, 1220 : 02/8134200 www.sopharma.bg
.
, , : 1797, . 3,
, : +359 2 8177413, : +359 2 9743759, e-mail: safety@sopharma.bg, www.sopharma.bg; , e-mail: bda@bda.bg

24610/27.05.2013

 ... ?

30% .(3)
270 000 .
25% ,
.
10% 15%
.
50% .(4)
30% 45%
( ).(4)

T ,
.(2)
250 mg Tribulus terrestris ( )
- 112,5 mg.

:(4)
, , 1 2
, ,
, , ,
/ 35 .

,
, .(5)
, ,
(6) ,
.(7)
()
.(6)

.(6-8)
.
.(8)

, ,
.(9-21)
,
2.(10, 11)

,
64%
/

II.(12)






,
.(6)



80%
.(6)

OH*

O*

H2O2 *

1 :
(6) Tremellen, K. Oxidative stress and male infertilitya clinical perspective. Hum Reprod Update 2008 (14): 243-258
(18) Negro-Vilar,A. Stress and Other Environmental Factors Aecting Fertility in Men and Women:Overview.
Environ Health Perspect. 1993 Jul;101 Suppl 2:59-64.

- ( 30 ),
, , , , .(13)

.(1)
()
()(1). , -
, ,
.(14)
5-alpha-,
(), -
(A) .(15)
- . -
, .(16)
(), ().
,
, ,
- (-) .(17)
,
.
,
40%, .(16)

2:
Arsyad K.M.1996 Result of Protodioscin (Tribulus terrestris) treatment in males diagnosed with infertility and impotence

-
(15)


212 14 60

:
39

50

53

-
20

50 impotentia coeundi

3 1
60 .

60-
,

90
-

(/)

(/)

26.66

22.97

21.00

22.00

23.00

24.00

25.00

26.00

27.00

35.66
29.00

10.00

15.00 20.00 25.00 30.00 35.00 40.00

3.67

1.95

0.50

1.00

0.00

20.00

1.50

2.00

2.50

90-
3 x 2

40.00

60.00

80.00

33.09

3.05

60-
3 x 1

(/)

0.00

(%)

5.00

76.00

40.60
26.75
21.31

60-
3 x 1

(%)

0.00

90-
3 x 2

11.53

0.00

10.00

20.00

3.50

4.00

30.00

40.00

50.00

(/)
90-
3 x 2

4.44

2.06

60-
3 x 1

3.00

39.06

2.00
0.00

1.00

2.00

3.00

4.44
4.00

5.00

3: I Viktorov, E. Bozadjieva, M. Protich, et al.

Pharmacological, pharmacokinetic, toxicological and clinical studies on protodioscin

,
- .
60-
,
90 -
.(15)